A nurse is assessing a 27-year-old patient who has been experiencing unexplained weight loss, night sweats, and fatigue for the past 2 months. Which assessment finding would be most characteristic of Hodgkin's lymphoma?

Painless, rubbery, movable lymph nodes are characteristic of Hodgkin's lymphoma. Other options represent findings more typical of other conditions.

Core Nursing Explanation Key Concept Analysis: This question tests the ability to identify the characteristic physical assessment finding of Hodgkin's lymphoma (HL). HL is a cancer of the lymphatic system, specifically involving the B-lymphocytes. A hallmark feature is the presence of Reed-Sternberg cells in the lymph node biopsy. The systemic symptoms (B symptoms) of unexplained weight loss, night sweats, and fatigue are classic, but the physical exam finding is key for suspicion and diagnosis.

Answer Rationale: Key Point! The most characteristic finding in Hodgkin's lymphoma is painless, enlarged lymph nodes that are described as rubbery in consistency and movable (not fixed to underlying tissues). These nodes are typically found in the cervical (neck), supraclavicular (above the collarbone), or axillary (armpit) regions. The "rubbery" feel is a classic descriptor in nursing and medical textbooks for HL nodes.

Distractor Analysis:
• Watch out for confusion! Option ① describes "multiple small, hard, fixed lymph nodes scattered throughout the body." This pattern is more characteristic of metastatic cancer (where cancer from another site spreads to lymph nodes) or some aggressive non-Hodgkin's lymphomas. In HL, nodes are typically larger, localized to one region initially, and movable.
• Option ②, "Severe abdominal pain with hepatosplenomegaly," is not a primary characteristic of HL. While advanced disease can involve the spleen and liver (causing enlargement), it is not the *most characteristic* initial finding. Severe abdominal pain is more typical of other abdominal pathologies.
• Option ④, "Petechiae and purpura on the extremities with bleeding gums," indicates thrombocytopenia (low platelet count), which is a sign of bone marrow suppression or infiltration. This can occur in late-stage HL or, more commonly, in leukemias or aplastic anemia, but it is not the defining physical assessment sign of HL.

Related Concepts: The "B symptoms" (fever >38°C, drenching night sweats, weight loss >10% body weight in 6 months) are crucial for staging and prognosis in HL. Staging (I-IV) determines treatment. Remember that while non-Hodgkin's lymphoma (NHL) can also cause lymphadenopathy, NHL nodes are often described as multiple, matted, and may grow rapidly. Concept Summary • Disease: Hodgkin's Lymphoma – Malignancy of B-lymphocytes with Reed-Sternberg cells.
• Key Symptom Triad: Unexplained weight loss, night sweats, fatigue ("B symptoms").
• Characteristic Physical Sign: Painless, rubbery, movable lymphadenopathy (often cervical/supraclavicular).
• Diagnostic Gold Standard: Excisional lymph node biopsy identifying Reed-Sternberg cells.
• Primary Treatment: Chemotherapy (e.g., ABVD regimen) and/or radiation therapy. Side-by-Side Comparison!

Feature	Hodgkin's Lymphoma (HL)	Non-Hodgkin's Lymphoma (NHL)
Characteristic Cell	Reed-Sternberg cell	Various (depends on subtype)
Lymph Node Presentation	Often localized, rubbery, movable	Often widespread, may be matted or fixed
Common Spread Pattern	Contiguous (orderly, from one node group to next)	Non-contiguous (skips around)
Extranodal Involvement	Less common early on	More common

Anatomy, Physiology & Pharmacology Points • Lymphatic System: Lymph nodes filter lymph and are sites of lymphocyte activation. Enlargement (lymphadenopathy) can be due to infection, inflammation, or malignancy.
• Pathophysiology In HL, malignant Reed-Sternberg cells are thought to originate from germinal center B-cells. They create an inflammatory microenvironment that leads to the characteristic symptoms.
• Pharmacology: First-line chemotherapy is often ABVD (Adriamycin/doxorubicin, Bleomycin, Vinblastine, Dacarbazine). Key nursing considerations: Monitor for cardiotoxicity (doxorubicin), pulmonary fibrosis (bleomycin), and neurotoxicity (vinblastine). Memory Tips • HL = "H" for Hard, movable lumps? No! Think Hodgkin's = Has Reed-Sternberg cells and Has orderly spread.
• Remember the node feel: "Rubbery like a pencil eraser, not rocky like a stone (metastasis)."
• B Symptoms: Think of the 3 W's: Weight loss, Wet night sweats, Warm fever. High-Frequency NCLEX Topics NCLEX loves to test the characteristic assessment findings of common cancers. For lymphoma, knowing the difference between the presentation of HL vs. NHL is high-yield. Also, be ready for questions on managing side effects of chemotherapy (like neutropenia precautions) for a patient with HL. Watch Out for Question Variations! • Instead of asking for the assessment finding, the question could ask: "The nurse identifies a painless, rubbery cervical lymph node. Which diagnostic test should the nurse anticipate?" (Answer: Lymph node biopsy).
• Or, it could shift to nursing priorities: "A patient with Hodgkin's lymphoma receiving ABVD chemotherapy reports shortness of breath. Which drug toxicity should the nurse suspect?" (Answer: Bleomycin-induced pulmonary fibrosis).

Nursing Clinical Practice Guide Clinical Scenario: You are a nurse in an outpatient clinic. A 27-year-old male presents with a 2-month history of feeling constantly tired, drenching night sweats that require changing his sheets, and a 15-pound weight loss without trying. He also mentions a "knot" on the side of his neck that doesn't hurt.

Nursing Intervention Strategy:
1. Assessment: Perform a thorough head-to-toe assessment. Palpate all lymph node chains (cervical, axillary, inguinal). Document the size, consistency (rubbery, hard, soft), mobility (fixed or movable), and tenderness of any enlarged nodes. Assess for hepatosplenomegaly by palpating the abdomen. Obtain a complete set of vital signs, noting any fever.
2. Nursing Diagnosis & Planning: Potential nursing diagnoses include Fatigue, Imbalanced Nutrition: Less Than Body Requirements, and Anxiety. The plan includes facilitating diagnostic workup, managing symptoms, and providing education and emotional support.
3. Implementation: Prepare the patient for diagnostic tests (CBC, ESR, LDH, CT scans, and ultimately lymph node biopsy). Educate on the importance of the biopsy for definitive diagnosis. Manage symptoms: encourage small, frequent, high-calorie meals; suggest moisture-wicking sleepwear for night sweats; and promote energy conservation.
4. Evaluation: Evaluate the patient's understanding of the diagnostic process, improvement in nutritional intake, and coping with anxiety.

Patient Safety and Precautions: After diagnosis and during treatment, the nurse must vigilantly monitor for signs of infection (fever, chills) due to chemotherapy-induced immunosuppression. Implement neutropenic precautions as ordered. Monitor for specific chemotherapy toxicities. Nursing Procedure & Medication Flow Pre-Biopsy Care: Ensure informed consent is obtained. Explain the procedure (often a surgical excision of the node under local or general anesthesia).
Post-Biopsy Care: Monitor the surgical site for bleeding, hematoma, or infection. Provide pain management as needed.
Chemotherapy Administration (ABVD):
• Verify the regimen and dosing using the "two-nurse check" protocol.
• Assess venous access. A central venous catheter (e.g., PICC line) is often used.
• Administer antiemetics prophylactically.
• Monitor for infusion reactions.
• For Doxorubicin: Assess cardiac function (baseline and periodic echocardiograms). Watch for extravasation—it is a vesicant!
• For Bleomycin: Monitor pulmonary function (listen for crackles, assess for dyspnea).
• For Vinblastine: Assess for neurotoxicity (numbness, tingling, constipation). A Word from Your Senior Nurse "When a young person comes in with those classic 'B symptoms' and a painless lump, your spider-sense should tingle for lymphoma. Your careful palpation and description of that lymph node—'rubbery and movable'—is a critical piece of data that pushes the provider toward the right diagnostic path. In oncology nursing, we're detectives and healers. We use our assessment skills to spot clues, and then we walk alongside our patients through the scary journey of diagnosis and treatment. Remember, your calm, knowledgeable presence makes all the difference."